New York Devil’s Claw Demand Returns DNA Barcoding To Industry Crosshairs
This article was originally published in The Tan Sheet
Executive Summary
NY AG Schneiderman’s demands that 13 firms pull devil's claw supplements from the market impress supplement industry stakeholders no more than his February orders, also based on DNA barcoding alone, for GNC and three mass merchandizers to remove allegedly adulterated herbal supplements from stores.